BackGlaukos Overview
Glaukos Corporation

Glaukos Target Price

Where could GKOS trade next? Consensus target price: $170.

Get informed when a big investor buys or sells

+ Follow

Share Price

$189.45

Average Target Price

$173.008.7% downside

15 analysts in the last 4 months

High: $215 | Low: $136

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30H.C. Wainwright$1952.9% upsideOpen
2026-07-30Stifel Nicolaus$1900.3% upsideOpen
2026-07-30Piper SandlerMatt O'Brien$1952.9% upsideOpen
2026-07-30Wells FargoLarry Biegelsen$1786% downsideOpen
2026-07-30NeedhamDavid Saxon$2016.1% upsideOpen
2026-07-30Truist FinancialRichard Newitter$21513.5% upsideOpen
2026-07-28UBS$15020.8% downsideOpen
2026-07-16Truist Financial$1805% downsideOpen
2026-07-13BTIG$16413.4% downsideOpen
2026-07-06H.C. Wainwright$16811.3% downsideOpen
2026-06-17NeedhamDavid Saxon$15020.8% downsideOpen
2026-05-21BTIGRyan Zimmerman$16214.5% downsideOpen
2026-04-30Stifel NicolausThomas Stephan$17010.3% downsideOpen
2026-04-30BTIG$14125.6% downsideOpen
2026-04-30Needham$13628.2% downsideOpen
2026-02-18NeedhamDavid Saxon$12733% downsideOpen
2026-02-18Wells Fargo$13528.7% downsideOpen
2026-01-28BTIG$13130.9% downsideOpen
2026-01-22Stifel Nicolaus$16015.5% downsideOpen
2026-01-14Piper Sandler$16512.9% downsideOpen
2026-01-09Goldman Sachs$13827.2% downsideOpen
2026-01-02Stephens$14523.5% downsideOpen
2025-12-23UBS$14523.5% downsideOpen
2025-12-18Truist Financial$14523.5% downsideOpen
2025-12-17UBS$16512.9% downsideOpen
2025-12-17Piper Sandler$6167.8% downsideOpen
2025-12-09Needham$12534% downsideOpen
2025-11-10UBSDanielle Antalffy$14026.1% downsideOpen
2025-10-30Truist FinancialRichard Newitter$12036.7% downsideOpen
2025-10-30BTIG$11638.8% downsideOpen
2025-10-30Wells Fargo$12235.6% downsideOpen
2025-10-30NeedhamDavid Saxon$11738.2% downsideOpen
2025-10-27Stifel NicolausThomas Stephan$11539.3% downsideOpen
2025-10-13BTIGRyan Zimmerman$10445.1% downsideOpen
2025-10-01Goldman Sachs$10345.6% downsideOpen
2025-07-31Mizuho Securities$13031.4% downsideOpen
2025-05-01Truist FinancialRichard Newitter$13528.7% downsideOpen
2024-12-31Stifel NicolausThomas Stephan$1757.6% downsideOpen
2024-12-18Truist FinancialRichard Newitter$1852.3% downsideOpen
2024-12-02Stifel NicolausThomas Stephan$15319.2% downsideOpen
2024-12-02Morgan StanleyPatrick Wood$12036.7% downsideOpen
2024-11-05NeedhamDavid Saxon$14921.4% downsideOpen
2024-11-05BTIGRyan Zimmerman$14026.1% downsideOpen
2024-10-29JefferiesMichael Sarcone$15518.2% downsideOpen
2024-10-21Truist FinancialSamuel Brodovsky$15219.8% downsideOpen
2024-10-17Piper SandlerMatt O'Brien$14026.1% downsideOpen
2024-09-23BTIGRyan Zimmerman$13926.6% downsideOpen
2024-09-03Stifel NicolausThomas Stephan$14523.5% downsideOpen
2024-06-05Stifel NicolausThomas Stephan$13031.4% downsideOpen
2024-06-03Wells FargoLarry Biegelsen$12036.7% downsideOpen

Glaukos (GKOS) FAQ

The latest target price for GKOS is $170. Investors often review this figure alongside Glaukos's historical trend and sector peers before judging valuation or financial health.

Glaukos trades near $189.45 while the consensus target sits at $170 (8.7% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting GKOS's target price ($170), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Glaukos's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.